Literature DB >> 18299204

Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells.

Atsuo Tahara1, Junko Tsukada, Yuichi Tomura, Takeyuki Yatsu, Masayuki Shibasaki.   

Abstract

Production of extracellular matrix proteins, such as type IV collagen, by mesangial cells contributes to progressive glomerulosclerosis. Transforming growth factor-beta (TGF-beta) modulates mesangial cell growth and stimulates extracellular matrix synthesis by mesangial cells. In this study, the ability of vasopressin (AVP), which causes mesangial cell proliferation and hypertrophy, to stimulate type IV collagen production and correlation with TGF-beta secretion by cultured rat mesangial cells was examined. AVP induced a time- and concentration-dependent increase in TGF-beta secretion and mitogenic effect in rat mesangial cells. This AVP-induced increase in TGF-beta secretion was potently inhibited by AVP V(1A) receptor-selective antagonist. AVP also induced a concentration-dependent increase in the production of type IV collagen and this effect was inhibited by V(1A) receptor-selective antagonist. Furthermore, TGF-beta also induced an increase in the production of type IV collagen; the AVP-enhanced production of type IV collagen was inhibited by an anti-TGF-beta antibody. These results demonstrate that AVP stimulates synthesis of type IV collagen by cultured rat mesangial cells through the induction of TGF-beta synthesis mediated by V(1A) receptors. Therefore, AVP-induced TGF-beta secretion by proliferating mesangial cells might act as an autocrine factor to regulate synthesis of extracellular matrix; this mechanism may contribute to glomerulosclerosis in renal diseases including diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299204     DOI: 10.1016/j.phrs.2008.01.003

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells.

Authors:  Tran D N Tran; Shaomian Yao; Walter H Hsu; Jeffrey M Gimble; Bruce A Bunnell; Henrique Cheng
Journal:  Mol Cell Endocrinol       Date:  2015-02-16       Impact factor: 4.102

2.  Effects of Averrhoa carambola L. (Oxalidaceae) juice mediated on hyperglycemia, hyperlipidemia, and its influence on regulatory protein expression in the injured kidneys of streptozotocin-induced diabetic mice.

Authors:  Hoa Thi Thai Pham; Wansu Huang; Chuangye Han; Juman Li; Qiuqiao Xie; Jinbin Wei; Xiaohui Xu; Zefeng Lai; Xiang Huang; Renbin Huang; Qingwei Wen
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

3.  Vasopressin in chronic kidney disease: an elephant in the room?

Authors:  Vicente E Torres
Journal:  Kidney Int       Date:  2009-11       Impact factor: 10.612

Review 4.  A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin.

Authors:  Gaurang P Mavani; Maria V DeVita; Michael F Michelis
Journal:  Front Med (Lausanne)       Date:  2015-03-24

5.  Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathy.

Authors:  Changrun Guo; Gang Ding; Wenzhe Huang; Zhenzhong Wang; Zhaoqing Meng; Wei Xiao
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

6.  Atorvastatin prevents glomerular extracellular matrix formation by interfering with the PKC signaling pathway.

Authors:  Yan-Hua Xiao; Xiao-Yun He; Qing Han; Fan Yang; Su-Xian Zhou
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

7.  Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy.

Authors:  Martín Muñoz-Ortega; Noé Macías-Segura; Javier Ventura-Juárez; Manuel Enrique Ávila-Blanco; Leonardo D Ponce-Damian; Daniel González-Blas; Esperanza Sánchez-Alemán; Andrés Quintanar-Stephano
Journal:  J Immunol Res       Date:  2021-12-09       Impact factor: 4.818

8.  Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease.

Authors:  Wei Yu; Ting Wang; Feng Wu; Yiding Zhang; Jin Shang; Zhanzheng Zhao
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.